Short-term hormone therapy plus radiation therapy increases survival for men with early-stage prostate cancer, study finds

Short-term hormone therapy (androgen deprivation therapy: ADT) given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared with that of those who receive the same radiation therapy alone, according to new research.